J. Douglas Rizzo

20.4k total citations · 4 hit papers
171 papers, 10.2k citations indexed

About

J. Douglas Rizzo is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, J. Douglas Rizzo has authored 171 papers receiving a total of 10.2k indexed citations (citations by other indexed papers that have themselves been cited), including 117 papers in Hematology, 63 papers in Public Health, Environmental and Occupational Health and 52 papers in Oncology. Recurrent topics in J. Douglas Rizzo's work include Hematopoietic Stem Cell Transplantation (98 papers), Acute Lymphoblastic Leukemia research (50 papers) and Childhood Cancer Survivors' Quality of Life (33 papers). J. Douglas Rizzo is often cited by papers focused on Hematopoietic Stem Cell Transplantation (98 papers), Acute Lymphoblastic Leukemia research (50 papers) and Childhood Cancer Survivors' Quality of Life (33 papers). J. Douglas Rizzo collaborates with scholars based in United States, Canada and France. J. Douglas Rizzo's co-authors include Mary M. Horowitz, John R. Wingard, Navneet S. Majhail, Stephanie J. Lee, Gèrard Socié, Kathleen A. Sobocinski, Fausto R. Loberiza, Brent R. Logan, Mary Eapen and Wael Saber and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

J. Douglas Rizzo

168 papers receiving 10.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

HLA Match Likelihoods for Hematopoietic Stem-Cell Grafts in the U.S. Registry

2014 690 citations Mary Eapen, Eric Williams et al. profile →
Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation

2014 611 citations Brent R. Logan, Richard T. Maziarz et al. Blood profile →
Long-Term Survival and Late Deaths After Allogeneic Hematopoietic Cell Transplantation

2011 443 citations John R. Wingard, Navneet S. Majhail et al. Journal of Clinical Oncology profile →
First- and Second-Line Systemic Treatment of Acute Graft-versus-Host Disease: Recommendations of the American Society of Blood and Marrow Transplantation

2012 423 citations J. Douglas Rizzo, John R. Wingard et al. Biology of Blood and Marrow Transplantation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. Douglas Rizzo United States	55	6.8k	3.3k	2.5k	1.9k	1.6k	171	10.2k
Navneet S. Majhail United States	51	5.1k 0.8×	3.0k 0.9×	2.6k 1.0×	1.9k 1.0×	959 0.6×	338	9.3k
Marcelo C. Pasquini United States	46	5.3k 0.8×	2.3k 0.7×	1.6k 0.6×	674 0.4×	1.7k 1.1×	246	7.6k
Enric Carreras Spain	52	5.1k 0.8×	2.2k 0.7×	1.2k 0.5×	717 0.4×	1.6k 1.0×	255	8.4k
Harry C. Schouten Netherlands	46	4.2k 0.6×	3.4k 1.0×	2.0k 0.8×	1.5k 0.8×	874 0.5×	182	9.9k
John A. Snowden United Kingdom	50	4.3k 0.6×	2.8k 0.9×	1.0k 0.4×	611 0.3×	2.0k 1.2×	261	9.1k
Josep‐María Ribera Spain	51	4.5k 0.7×	3.5k 1.1×	2.7k 1.1×	746 0.4×	1.1k 0.7×	432	9.6k
Sy Ha China	53	4.2k 0.6×	2.6k 0.8×	1.1k 0.4×	1.0k 0.5×	844 0.5×	341	14.3k
K. Scott Baker United States	50	2.1k 0.3×	1.8k 0.6×	2.2k 0.9×	3.4k 1.8×	366 0.2×	140	7.0k
Lisa Rybicki United States	57	1.5k 0.2×	4.3k 1.3×	1.8k 0.7×	1.4k 0.7×	634 0.4×	408	13.0k
Sima Jeha United States	51	3.4k 0.5×	2.2k 0.7×	4.8k 1.9×	3.1k 1.6×	516 0.3×	221	9.1k

Countries citing papers authored by J. Douglas Rizzo

Since Specialization

Citations

This map shows the geographic impact of J. Douglas Rizzo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Douglas Rizzo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Douglas Rizzo more than expected).

Fields of papers citing papers by J. Douglas Rizzo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Douglas Rizzo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Douglas Rizzo. The network helps show where J. Douglas Rizzo may publish in the future.

Co-authorship network of co-authors of J. Douglas Rizzo

This figure shows the co-authorship network connecting the top 25 collaborators of J. Douglas Rizzo. A scholar is included among the top collaborators of J. Douglas Rizzo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Douglas Rizzo. J. Douglas Rizzo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Leone, Lorenzo, J. Douglas Rizzo, Jens Eisert, & Sofiène Jerbi. (2025). Entanglement theory with limited computational resources. Nature Physics. 21(11). 1847–1854.

Rizzo, J. Douglas, et al.. (2024). Evaluating washing techniques to eliminate external contamination of trace elements in bat fur and bird feathers. Ecotoxicology and Environmental Safety. 283. 116819–116819. 2 indexed citations

Turcotte, Lucie M., Kirsten Beyer, Steve W. Cole, et al.. (2024). The health risk of social disadvantage is transplantable into a new host. Proceedings of the National Academy of Sciences. 121(30). e2404108121–e2404108121. 2 indexed citations

Cusatis, Rachel, Kathryn E. Flynn, Sumithira Vasu, et al.. (2021). Adding Centralized Electronic Patient-Reported Outcome Data Collection to an Established International Clinical Outcomes Registry. Transplantation and Cellular Therapy. 28(2). 112.e1–112.e9. 4 indexed citations

Knight, Jennifer M., J. Douglas Rizzo, Parameswaran Hari, et al.. (2020). Propranolol inhibits molecular risk markers in HCT recipients: a phase 2 randomized controlled biomarker trial. Blood Advances. 4(3). 467–476. 39 indexed citations

Chhabra, Saurabh, Parameswaran Hari, Alexis Visotcky, et al.. (2019). A Phase I/2 Study of Ixazomib for Chronic Graft-Versus-Host Disease (cGVHD) Prophylaxis after Allogeneic Transplantation (alloHCT).. Biology of Blood and Marrow Transplantation. 25(3). S224–S225. 1 indexed citations

Majhail, Navneet S., Lih-Wen Mau, Pintip Chitphakdithai, et al.. (2019). Transplant center characteristics and survival after allogeneic hematopoietic cell transplantation in adults. Bone Marrow Transplantation. 55(5). 906–917. 26 indexed citations

Murthy, Guru Subramanian Guru, Parameswaran Hari, Anikó Szabó, et al.. (2018). Outcomes of Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation Performed in the Inpatient versus Outpatient Setting. Biology of Blood and Marrow Transplantation. 25(4). 827–833. 24 indexed citations

Raj, Renju, Mehdi Hamadani, Anikó Szabó, et al.. (2018). Peripheral Blood Grafts for T Cell–Replete Haploidentical Transplantation Increase the Incidence and Severity of Cytokine Release Syndrome. Biology of Blood and Marrow Transplantation. 24(8). 1664–1670. 31 indexed citations

10.

Kanate, Abraham S., Parameswaran Hari, Marcelo C. Pasquini, et al.. (2017). Recipient Immune Modulation with Atorvastatin for Acute Graft-versus-Host Disease Prophylaxis after Allogeneic Transplantation. Biology of Blood and Marrow Transplantation. 23(8). 1295–1302. 10 indexed citations

11.

D’Souza, Anita, Heather R. Millard, Jennifer M. Knight, et al.. (2017). Patient-Reported Sleep Quality at Baseline Correlates with 1-Year Survival after Allogeneic Hematopoietic Cell Transplantation in Adults. Blood. 130. 3447–3447. 1 indexed citations

12.

Knight, Jennifer M., Karen L. Syrjala, Navneet S. Majhail, et al.. (2016). Patient-Reported Outcomes and Socioeconomic Status as Predictors of Clinical Outcomes after Hematopoietic Stem Cell Transplantation: A Study from the Blood and Marrow Transplant Clinical Trials Network 0902 Trial. Biology of Blood and Marrow Transplantation. 22(12). 2256–2263. 17 indexed citations

13.

Cornell, Robert F., Xiaobo Zhong, Carlos Arce‐Lara, et al.. (2015). Bortezomib-based induction for transplant ineligible AL amyloidosis and feasibility of later transplantation. Bone Marrow Transplantation. 50(7). 914–917. 21 indexed citations

14.

Bredeson, Christopher, Jennifer Le‐Rademacher, Kazunobu Kato, et al.. (2013). Prospective cohort study comparing intravenous busulfan to total body irradiation in hematopoietic cell transplantation. Blood. 122(24). 3871–3878. 88 indexed citations

15.

Hahn, Theresa, Philip L. McCarthy, Anna Hassebroek, et al.. (2013). Significant Improvement in Survival After Allogeneic Hematopoietic Cell Transplantation During a Period of Significantly Increased Use, Older Recipient Age, and Use of Unrelated Donors. Journal of Clinical Oncology. 31(19). 2437–2449. 175 indexed citations

16.

Bredeson, Christopher, Jennifer Le‐Rademacher, Xiaochun Zhu, et al.. (2013). Improved Survival with Intravenous Busulfan (IV BU) Compared to Total Body Irradiation (TBI)-Based Myeloablative Conditioning Regimens: A CIBMTR Prospective Study. Biology of Blood and Marrow Transplantation. 19(2). S110–S111. 3 indexed citations

17.

Wingard, John R., I‐Chan Huang, Kathleen A. Sobocinski, et al.. (2010). Factors Associated with Self-Reported Physical and Mental Health after Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 16(12). 1682–1692. 36 indexed citations

18.

Schmitz, Norbert, Mary Eapen, Mary M. Horowitz, et al.. (2006). Long-term outcome of patients given transplants of mobilized blood or bone marrow: a report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation. Blood. 108(13). 4288–4290. 97 indexed citations

19.

Navarro, Willis H., Fausto R. Loberiza, Ruta Bajorunaite, et al.. (2006). Effect of Body Mass Index on Mortality of Patients with Lymphoma Undergoing Autologous Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 12(5). 541–551. 79 indexed citations

20.

Rizzo, J. Douglas. (2005). Evidence-based medicine: can it be applied to stimulation of erythropoiesis for patients with malignancy?. Best Practice & Research Clinical Haematology. 18(3). 439–448. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact